title: Targeting B lymphocytes in progressive fibrosing mediastinitis.
authors.affiliation: 1 Mayo Clinic Rochester, Minnesota.
authors.forename: Blair D
authors.initials: BD
authors.lastname: Westerly
authors.forename: Geoffrey B
authors.initials: GB
authors.lastname: Johnson
authors.forename: Fabien
authors.initials: F
authors.lastname: Maldonado
authors.forename: James P
authors.initials: JP
authors.lastname: Utz
authors.forename: Ulrich
authors.initials: U
authors.lastname: Specks
authors.forename: Tobias
authors.initials: T
authors.lastname: Peikert
mesh_terms: D000328:Adult; D058846:Antibodies, Monoclonal, Murine-Derived / Q000627:therapeutic use*; D001402:B-Lymphocytes / Q000187:drug effects*; D018450:Disease Progression; D005260:Female; D006801:Humans; D008297:Male; D008480:Mediastinitis / Q000188:drug therapy*; D008875:Middle Aged; D000069283:Rituximab; D012598:Sclerosis / Q000188:drug therapy*
chemical_list: D058846:Antibodies, Monoclonal, Murine-Derived; D000069283:Rituximab